In both TMAs, CA9 staining was significantly stronger in NEPC compared to primary adeno-PCa and adeno-CRPC (Fig. 5a–c), indicating that NEPC is more hypoxic than prostate adenocarcinoma. This evidence concerns the gene CA9 and prostate adenocarcinoma.